Buzzkill Labs, a Livermore, CA-based developer of a saliva test for psychoactive THC, raised an undisclosed amount in Series A funding.
The round was led by Poseidon and existing investors. Buzzkill also announced the appointment of Patrick Rea, Managing Director of Poseidon Garden Ventures, to its Board of Directors.
The company intends to use the funds to commercialize its technology, which fills employers’ critical need to maintain safe workplaces while respecting the dignity of employees who legally use cannabis outside of work.
Founded in 2018 and led by CEO Jeff Heimburger and CTO George Farquar, Ph.D., Buzzkill Labs has developed patented technologies for rapid, cost-effective detection of organic compounds. The proprietary technology performs on-site detection of psychoactive THC in saliva (oral fluid) samples in less than 15 minutes. The platform, initially deployed in workplace safety applications, enables employers with safety-sensitive roles to identify the use of cannabis during or immediately before work hours.
FinSMEs
17/05/2023